Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 13, 2018
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang, Margaret M Billingsley, Michael J Mitchell
Science Advances
|
February 23, 2022
Lighting the way to personalized mRNA immune cell therapies
Ann E Metzloff, Margaret M Billingsley, Michael J Mitchell
Plos One
|
May 12, 2017
Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods
Margaret M Billingsley, Rachel S Riley, Emily S Day
Ebiomedicine
|
April 28, 2021
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy
Ella S Atsavapranee, Margaret M Billingsley, Michael J Mitchell
Journal of Visualized Experiments : Jove
|
February 6, 2023
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
Rakan El-Mayta, Marshall S Padilla, Margaret M Billingsley, et al.
Advanced Drug Delivery Reviews
|
February 11, 2024
Emerging strategies for nanomedicine in autoimmunity
Ajay S Thatte, Margaret M Billingsley, Drew Weissman, et al.
Nature Nanotechnology
|
January 13, 2021
Nanomaterials for T-cell cancer immunotherapy
Ningqiang Gong, Neil C Sheppard, Margaret M Billingsley, et al.
Nano Letters
|
January 18, 2020
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Margaret M Billingsley, Nathan Singh, Pranali Ravikumar, et al.
Nano Letters
|
April 28, 2018
Evaluating the Mechanisms of Light-Triggered siRNA Release from Nanoshells for Temporal Control Over Gene Regulation
Rachel S Riley, Megan N Dang, Margaret M Billingsley, et al.
Nature Reviews. Drug Discovery
|
December 5, 2020
Engineering precision nanoparticles for drug delivery
Michael J Mitchell, Margaret M Billingsley, Rebecca M Haley, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 13, 2018
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang, Margaret M Billingsley, Michael J Mitchell
Science Advances
|
February 23, 2022
Lighting the way to personalized mRNA immune cell therapies
Ann E Metzloff, Margaret M Billingsley, Michael J Mitchell
Plos One
|
May 12, 2017
Antibody-nanoparticle conjugates to enhance the sensitivity of ELISA-based detection methods
Margaret M Billingsley, Rachel S Riley, Emily S Day
Ebiomedicine
|
April 28, 2021
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy
Ella S Atsavapranee, Margaret M Billingsley, Michael J Mitchell
Journal of Visualized Experiments : Jove
|
February 6, 2023
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
Rakan El-Mayta, Marshall S Padilla, Margaret M Billingsley, et al.
Advanced Drug Delivery Reviews
|
February 11, 2024
Emerging strategies for nanomedicine in autoimmunity
Ajay S Thatte, Margaret M Billingsley, Drew Weissman, et al.
Nature Nanotechnology
|
January 13, 2021
Nanomaterials for T-cell cancer immunotherapy
Ningqiang Gong, Neil C Sheppard, Margaret M Billingsley, et al.
Nano Letters
|
January 18, 2020
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Margaret M Billingsley, Nathan Singh, Pranali Ravikumar, et al.
Nano Letters
|
April 28, 2018
Evaluating the Mechanisms of Light-Triggered siRNA Release from Nanoshells for Temporal Control Over Gene Regulation
Rachel S Riley, Megan N Dang, Margaret M Billingsley, et al.
Nature Reviews. Drug Discovery
|
December 5, 2020
Engineering precision nanoparticles for drug delivery
Michael J Mitchell, Margaret M Billingsley, Rebecca M Haley, et al.
Page
of 4